Antonia Högnäsbacka

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsGene and molecular therapyVeterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 16, 2024
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.

Antonia A Högnäsbacka, Alex J Poot, Christophe Plisson

|Dec 21, 2023
Validation of a good manufacturing practice procedure for the production of [11C]AZD4747, a CNS penetrant KRASG12c inhibitor.

Miguel A Cortés González, Antonia A Högnäsbacka, Christer Halldin

|Aug 30, 2023
Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase.

Antonia A Högnäsbacka, Alex J Poot, Esther Kooijman

|Aug 18, 2022
Simplified and accessible [18 F]F-AraG synthesis procedure for preclinical PET.

Antonia A Högnäsbacka, Miguel A Cortés González, Christer Halldin

|Apr 23, 2022
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor.

Antonia Högnäsbacka, Alex J Poot, Danielle J Vugts

Pageof 1

Frequent Collaborators

2 joint publications

Miguel A Cortés González

2 joint publications

Magnus Schou

2 joint publications

Albert D Windhorst

1 joint publications

Christer Halldin